Sector Investors News and Insights

Amgen’s stock drops after Cantor raises concerns about an obesity drug.

Amgen sinks as Cantor flags issues with obesity drug…

Read More: https://www.youtube.com/watch?v=NDWPb53_eew

More News

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.